Ocular Therapeutix Inc. announced amendments to its corporate bylaws following the 2025 Annual Meeting of Stockholders. The amendments include an increase of 8,750,000 shares in the 2021 Stock Incentive Plan and an amendment to the 2014 Employee Stock Purchase Plan, adding 2,000,000 shares while eliminating annual "evergreen" share increases. Additionally, the company's Restated Certificate of Incorporation was updated to extend exculpation provisions to certain senior officers, effective upon filing with the Delaware Secretary of State.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.